Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.20 per share, beating the Zacks Consensus Estimate of $4.10 per share. This compares to earnings of $3.76 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.44%. A quarter ago, it was expected that this drugmaker would post earnings of $3.92 per share when it actually produced earnings of $4.08, delivering a surprise of 4.08%.Over the last four quarters, the c ...